APGE Operating Cash Flow (Statement)
Apogee Therapeutics Inc · Operating Cash Flow (Statement)
APGE Operating Cash Flow (Statement)
Latest reported-$243.89Mperiod ending
APGE Cash from Operations (-$16.43M → -$243.89M)
Annual operating cash flow (statement)
High-resolution chart · PNG
APGE operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -227,450,000 | |
| -171,174,000 | |
| -74,761,000 | |
| -16,427,000 |